VVOS Stock Analysis: Buy, Sell, or Hold?
VVOS - Vivos Therapeutics, Inc. Common Stock
$1.14
-0.01 (-0.87%)
▼
5d:
-3.39%
30d:
-18.57%
90d:
-43.84%
HOLD
MODERATE Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: Mar 30, 2026
0d
Get Alerted When VVOS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VVOS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VVOS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VVOS is currently trading at $1.14, which is considered oversold relative to its 30-day fair value range of $1.20 to $1.48.
Technical Outlook: Technically, VVOS is in a strong downtrend. Immediate support is located at $1.09, while resistance sits at $1.45.
Market Sentiment: VVOS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+334.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VVOS is in a strong downtrend. Immediate support is located at $1.09, while resistance sits at $1.45.
Market Sentiment: VVOS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+334.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.20 -
$1.48
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 334.8% below Wall St target ($5.00)
Fair Price Analysis
30-Day Fair Range
$1.20 -
$1.48
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.09
Resistance Level
$1.45
Current Trend
Strong Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.92
Wall Street Target
$5.00
(+334.8%)
Revenue Growth (YoY)
75.7%
Profit Margin
-98.8%
Share & Embed Analysis
Last updated: March 30, 2026 10:26 AM ET
Data refreshes hourly during market hours. Next update: 11:26 AM
Data refreshes hourly during market hours. Next update: 11:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VVOS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 56 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 48 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 56 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 56 HOLD |
